After MIA Calls for Retraction of STAR*D Article, Study Authors Double Down on the Fraud
In their letter to the editor, Rush et al. have doubled-down on the fraud they committed in their 2006 summary report of STAR*D outcomes.
Stay updated with breaking news from Michael Thase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In their letter to the editor, Rush et al. have doubled-down on the fraud they committed in their 2006 summary report of STAR*D outcomes.
2009 report posted for filing Contact: Clare Collins CollCX@upmc.edu 412-647-3555 University of Pittsburgh Schools of the Health Sciences Are we cherry picking participants for studies of antidepressants? People with depression often excluded from clinical studies and tend not to fare as well as study participants PITTSBURGH, April 28 – Findings from clinical studies used to…
A new study shows antidepressants outperformed placebo in only 15% of patients, almost exclusively in those with the most severe depression.
Do antidepressants really provide lasting relief? Here's what the industry desperately doesn't want you to know. STORY AT-A-GLANCE ...
Popular meds work no better than a placebo for depression and can come with severe withdrawal symptoms. Why do doctors prescribe them to 43 million Americans?